Reuters logo
BRIEF-Ocera completes enrollment of Phase 2B study of OCR-002 in hepatic encephalopathy patients
December 7, 2016 / 2:25 PM / 10 months ago

BRIEF-Ocera completes enrollment of Phase 2B study of OCR-002 in hepatic encephalopathy patients

Dec 7 (Reuters) - Ocera Therapeutics Inc :

* Ocera Therapeutics Inc - expect to report top-line data for OCR-002 in Q1 of 2017

* Ocera completes enrollment of STOP-HE, a Phase 2b study of OCR-002 in hospitalized patients with hepatic encephalopathy Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below